{
    "clinical_study": {
        "@rank": "21596", 
        "acronym": "HEPMEN", 
        "arm_group": {
            "arm_group_label": "Healthy women", 
            "description": "Non interventional"
        }, 
        "biospec_descr": {
            "textblock": "Hepcidin Serum iron Transfferin saturation Serum transfferin Serum ferritin"
        }, 
        "biospec_retention": "Samples Without DNA", 
        "brief_summary": {
            "textblock": "Hepcidin is the major hormone regulating Iron Metabolism. In a normal  organism decrease\n      iron stock causes a decrease in hepcidin synthesis thus promoting intestinal absorption of\n      iron.\n\n      The interpretation of hepcidin dosage results requires to know the  physiological variations\n      of this hormone.\n\n      This study investigate whether there are significant variations in the values of serum\n      hepcidin rates during the menstrual cycle in order to make recommendations on the practical\n      dosage determination of hepcidin in premenopausal women."
        }, 
        "brief_title": "Study of Serum Hepcidin Rate Variations During Menstrual Cycle", 
        "completion_date": {
            "#text": "August 2014", 
            "@type": "Anticipated"
        }, 
        "condition": "Healthy Women", 
        "detailed_description": {
            "textblock": "Hepcidin is the major hormone regulating Iron Metabolism. Synthesized primarily by\n      hepatocytes, it interacts with the cellular iron exporter ferroportin, causing its\n      internalization and preventing the release of iron from enterocytes and macrophages.\n\n      In a normal  organism decrease iron stock causes a decrease in hepcidin synthesis thus\n      promoting intestinal absorption of iron.\n\n      Since valid methods for the determination of hepcidin serum rate are available, this dosage\n      is increasingly used to diagnosis iron metabolism pathologies, in particular iron overload.\n      The interpretation of hepcidin dosage results requires to know  physiological variations of\n      this hormone.\n\n      Several works have shown that hepcidin varies according to a circadian cycle, that its\n      values differ by sex and, in women, by age. As far as the investigators know, no study has\n      focused on possible variations in serum hepcidin rates values during menstrual cycle in\n      women. Yet this question seems relevant since it has been shown that during the menstrual\n      cycle blood loss can cause significant iron and hemoglobin  variations, which can\n      significantly modulate the synthesis of hepcidin.\n\n      This study investigate whether there are significant variations in the values of serum\n      hepcidin rates during the menstrual cycle in order to make recommendations on the practical\n      dosage determination of hepcidin in premenopausal women."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Woman aged over 18 and under 45 years,\n\n          -  Having given free and informed written consent,\n\n          -  Having regular cycles (defined by a constant interval between periods of 28 to 30\n             days),\n\n          -  Having periods for a duration of 4 + / - 1 days\n\n          -  Not using contraception or using oral oestroprogestative contraception.\n\n        Exclusion Criteria:\n\n          -  Contraceptive IUD\n\n          -  Metrorrhagia\n\n          -  Pregnancy,\n\n          -  BMI under 18 kg / m\u00b2 and above 30 kg / m\u00b2,\n\n          -  Presence of at least one of the following abnormalities in serum iron balance :\n             Hemoglobin <11.5 g / dl, transferrin saturation under 15% or greater than 50%, serum\n             ferritin under 15\u03bcg / l or greater than 150 \u00b5g / l\n\n          -  Active smoking or quit within the last 6 months\n\n          -  Drinking more than 20 g of alcohol per day ,\n\n          -  Iron supplementation or blood transfusion within 12 months before inclusion\n\n          -  Blood donation within 3 months before inclusion,\n\n          -  Stay in altitude> 1500 m in the previous month before inclusion\n\n          -  Chronic inflammatory disease,\n\n          -  Incapable people over 18 (judicial protection, guardianship) and persons deprived of\n             their liberty."
            }, 
            "gender": "Female", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "45 Years", 
            "minimum_age": "18 Years", 
            "sampling_method": "Non-Probability Sample", 
            "study_pop": {
                "textblock": "Healthy women"
            }
        }, 
        "enrollment": {
            "#text": "90", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "January 7, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01764412", 
            "org_study_id": "2012-A01122-41"
        }, 
        "intervention_browse": {
            "mesh_term": "Hepcidin"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "Healthy women", 
            "Menstrual cycle", 
            "Hepcidin", 
            "Seric iron"
        ], 
        "lastchanged_date": "January 27, 2014", 
        "location": [
            {
                "contact": {
                    "email": "fabrice.laine@chu-rennes.fr", 
                    "last_name": "Fabrice Lain\u00e9, MD", 
                    "phone": "299289201", 
                    "phone_ext": "+33"
                }, 
                "facility": {
                    "address": {
                        "city": "Rennes", 
                        "country": "France", 
                        "state": "Bretagne", 
                        "zip": "35000"
                    }, 
                    "name": "CHU Rennes"
                }, 
                "investigator": {
                    "last_name": "Fabrice Lain\u00e9, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "cic_centre_ressources_methodologique@chu-brest.fr", 
                    "last_name": "Karine Lacut, MDPhD", 
                    "phone": "2 98 34 50 00", 
                    "phone_ext": "+33"
                }, 
                "facility": {
                    "address": {
                        "city": "Brest", 
                        "country": "France", 
                        "zip": "29200"
                    }, 
                    "name": "Chu Brest"
                }, 
                "investigator": {
                    "last_name": "Karine Lacut, MDPhD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Sylvie Sacher-Huvelin, MD", 
                    "phone": "2.40.08.31.52", 
                    "phone_ext": "+33"
                }, 
                "facility": {
                    "address": {
                        "city": "Nantes", 
                        "country": "France", 
                        "zip": "44000"
                    }, 
                    "name": "CHU Nantes"
                }, 
                "investigator": {
                    "last_name": "Sylvie Sacher-Huvelin, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "email": "valerie.gissot@univ-tours.fr", 
                    "last_name": "Val\u00e9rie Gissot, MD", 
                    "phone": "2 34 37 96 53", 
                    "phone_ext": "+33"
                }, 
                "facility": {
                    "address": {
                        "city": "Tours", 
                        "country": "France", 
                        "zip": "37000"
                    }, 
                    "name": "Chru Tours"
                }, 
                "investigator": {
                    "last_name": "Val\u00e9rie Gissot, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }
        ], 
        "location_countries": {
            "country": "France"
        }, 
        "number_of_groups": "1", 
        "official_title": "Study of Serum Hepcidin Rate Variations During Menstrual Cycle", 
        "overall_contact": {
            "email": "fabrice.laine@chu-rennes.fr", 
            "last_name": "Fabrice Lain\u00e9, MD", 
            "phone": "2 99 28 92 01", 
            "phone_ext": "+33"
        }, 
        "overall_official": {
            "affiliation": "CHU de Rennes - CIC INSERM 0203", 
            "last_name": "Fabrice lain\u00e9, MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "France: Agence Nationale de S\u00e9curit\u00e9 du M\u00e9dicament et des produits de sant\u00e9", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "August 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Time frame : depending on the calendar day of D1 as the following calendars (D1: first day after periods beginning)\nD1 occurring on Monday : D1, D3, D4, D8, D15, D26\nD1 occurring on Tuesday : D1, D2, D4, D7, D11, D28\nD1 occurring on Wednesday : D1, D2, D6, D7, D13, D28\nD1 occurring on Thursday : D1, D2, D5, D6, D13, D28\nD1 occurring on Friday :  D1, D4, D5, D6, D11, D27\nD1 occurring on Saturday : D3, D4, D5, D12, D20, D27\nD1 occurring on Sunday :  D3, D4, D5, D12, D19, D26", 
            "measure": "Serum hepcidin rates variations during the menstrual cycle", 
            "safety_issue": "No", 
            "time_frame": "During the menstrual cycle (see description)"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01764412"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "description": "Time frame : depending on the calendar day of D1 as the following calendars (D1: first day after periods beginning)\nD1 occurring on Monday : D1, D3, D4, D8, D15, D26\nD1 occurring on Tuesday : D1, D2, D4, D7, D11, D28\nD1 occurring on Wednesday : D1, D2, D6, D7, D13, D28\nD1 occurring on Thursday : D1, D2, D5, D6, D13, D28\nD1 occurring on Friday : D1, D4, D5, D6, D11, D27\nD1 occurring on Saturday : D3, D4, D5, D12, D20, D27\nD1 occurring on Sunday : D3, D4, D5, D12, D19, D26", 
                "measure": "Seric iron", 
                "safety_issue": "No", 
                "time_frame": "During the menstrual cycle (see description)"
            }, 
            {
                "description": "Time frame : depending on the calendar day of D1 as the following calendars (D1: first day after periods beginning)\nD1 occurring on Monday : D1, D3, D4, D8, D15, D26\nD1 occurring on Tuesday : D1, D2, D4, D7, D11, D28\nD1 occurring on Wednesday : D1, D2, D6, D7, D13, D28\nD1 occurring on Thursday : D1, D2, D5, D6, D13, D28\nD1 occurring on Friday : D1, D4, D5, D6, D11, D27\nD1 occurring on Saturday : D3, D4, D5, D12, D20, D27\nD1 occurring on Sunday : D3, D4, D5, D12, D19, D26", 
                "measure": "transferrin saturation", 
                "safety_issue": "No", 
                "time_frame": "During the menstrual cycle (see description)"
            }, 
            {
                "description": "Time frame : depending on the calendar day of D1 as the following calendars (D1: first day after periods beginning)\nD1 occurring on Monday : D1, D3, D4, D8, D15, D26\nD1 occurring on Tuesday : D1, D2, D4, D7, D11, D28\nD1 occurring on Wednesday : D1, D2, D6, D7, D13, D28\nD1 occurring on Thursday : D1, D2, D5, D6, D13, D28\nD1 occurring on Friday : D1, D4, D5, D6, D11, D27\nD1 occurring on Saturday : D3, D4, D5, D12, D20, D27\nD1 occurring on Sunday : D3, D4, D5, D12, D19, D26", 
                "measure": "serum transferrin", 
                "safety_issue": "No", 
                "time_frame": "During the menstrual cycle (see description)"
            }, 
            {
                "description": "Time frame : depending on the calendar day of D1 as the following calendars (D1: first day after periods beginning)\nD1 occurring on Monday : D1, D3, D4, D8, D15, D26\nD1 occurring on Tuesday : D1, D2, D4, D7, D11, D28\nD1 occurring on Wednesday : D1, D2, D6, D7, D13, D28\nD1 occurring on Thursday : D1, D2, D5, D6, D13, D28\nD1 occurring on Friday : D1, D4, D5, D6, D11, D27\nD1 occurring on Saturday : D3, D4, D5, D12, D20, D27\nD1 occurring on Sunday : D3, D4, D5, D12, D19, D26", 
                "measure": "serum ferritin", 
                "safety_issue": "No", 
                "time_frame": "During the menstrual cycle (see description)"
            }, 
            {
                "description": "Time frame : depending on the calendar day of D1 as the following calendars (D1: first day after periods beginning)\nD1 occurring on Monday : D1, D3, D4, D8, D15, D26\nD1 occurring on Tuesday : D1, D2, D4, D7, D11, D28\nD1 occurring on Wednesday : D1, D2, D6, D7, D13, D28\nD1 occurring on Thursday : D1, D2, D5, D6, D13, D28\nD1 occurring on Friday : D1, D4, D5, D6, D11, D27\nD1 occurring on Saturday : D3, D4, D5, D12, D20, D27\nD1 occurring on Sunday : D3, D4, D5, D12, D19, D26", 
                "measure": "hepcidin / ferritin rate", 
                "safety_issue": "No", 
                "time_frame": "During the menstrual cycle (see description)"
            }, 
            {
                "description": "Time frame : depending on the calendar day of D1 as the following calendars (D1: first day after periods beginning)\nD1 occurring on Monday : D1, D3, D4, D8, D15, D26\nD1 occurring on Tuesday : D1, D2, D4, D7, D11, D28\nD1 occurring on Wednesday : D1, D2, D6, D7, D13, D28\nD1 occurring on Thursday : D1, D2, D5, D6, D13, D28\nD1 occurring on Friday : D1, D4, D5, D6, D11, D27\nD1 occurring on Saturday : D3, D4, D5, D12, D20, D27\nD1 occurring on Sunday : D3, D4, D5, D12, D19, D26", 
                "measure": "hepcidin / transferrin saturation rate", 
                "safety_issue": "No", 
                "time_frame": "During the menstrual cycle (see description)"
            }, 
            {
                "description": "Time frame : depending on the calendar day of D1 as the following calendars (D1: first day after periods beginning)\nD1 occurring on Monday : D1, D3, D4, D8, D15, D26\nD1 occurring on Tuesday : D1, D2, D4, D7, D11, D28\nD1 occurring on Wednesday : D1, D2, D6, D7, D13, D28\nD1 occurring on Thursday : D1, D2, D5, D6, D13, D28\nD1 occurring on Friday : D1, D4, D5, D6, D11, D27\nD1 occurring on Saturday : D3, D4, D5, D12, D20, D27\nD1 occurring on Sunday : D3, D4, D5, D12, D19, D26", 
                "measure": "hepcidin / serum iron rate", 
                "safety_issue": "No", 
                "time_frame": "During the menstrual cycle (see description)"
            }
        ], 
        "source": "Rennes University Hospital", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Rennes University Hospital", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "March 2013", 
        "study_design": "Observational Model: Cohort, Time Perspective: Prospective", 
        "study_type": "Observational", 
        "verification_date": "January 2014"
    }
}